Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03691740
Other study ID # Pro00031969
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 6, 2018
Est. completion date June 2019

Study information

Verified date September 2018
Source University of South Florida
Contact Judette M Louis, MD
Phone 8132598500
Email jlouis1@health.usf.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective in the current study is to test the hypothesis that nocturnal uterine contractions in preterm women can be suppressed by brief ocular exposure to blue light.The Olcese lab at Florida State University identified a novel interaction between the myometrial melatonin receptors and OT receptors in human myometrial cells (Sharkey et al. 2009), which may ultimately help to resolve certain issues surrounding idiopathic preterm labor. Their results consistently indicate that melatonin at physiological concentration sensitizes human myometrial smooth muscle cells to the contractile effects of OT (Sharkey et al. 2010).


Description:

Study participants will be pregnant women (gestational weeks 24 to 31+6 days) who present with preterm contractions. In the triage room, the study participant will be connected to the external tocometer from at least 19:00h (7 PM) to the following morning at 07:00h. Room lighting will be kept dim.

Participants meeting inclusion criteria will be randomly allocated to blue light or red light. Baseline contractions will be measured. The allocated light mask will be applied for 2 intervals of 60 minutes each.There will be a 60 minute rest period after every 60 minute intervention period for comparison.

Other than the application of the light mask, all routine standards of care deemed warranted by the obstetric provider for proper treatment of preterm labor will be followed. (ie antenatal steroids, tocolytics).


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date June 2019
Est. primary completion date June 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Pregnant

- Gestational age: 24 to 31 (+6 days) week of pregnancy

- Uterine contractions

- First episode of preterm labor

Exclusion Criteria:

- Visual impairment (legally blind)

- Multiple pregnancy

- Current progesterone treatment

- Preeclampsia

- Renal disease

- Current chlamydia or gonorrhea infections

- Cocaine or opiate use

- Nightshift work in the past week

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ocular light
A light mask to which small light emitting diode(LED) lights emitting a blue or red color light will be used to deliver ocular light

Locations

Country Name City State
United States Tampa General Hospital Tampa Florida

Sponsors (2)

Lead Sponsor Collaborator
University of South Florida Kyndermed

Country where clinical trial is conducted

United States, 

References & Publications (4)

Olcese J, Beesley S. Clinical significance of melatonin receptors in the human myometrium. Fertil Steril. 2014 Aug;102(2):329-35. doi: 10.1016/j.fertnstert.2014.06.020. Epub 2014 Jul 9. Review. — View Citation

Olcese J, Lozier S, Paradise C. Melatonin and the circadian timing of human parturition. Reprod Sci. 2013 Feb;20(2):168-74. doi: 10.1177/1933719112442244. Epub 2012 May 3. Review. — View Citation

Sharkey JT, Cable C, Olcese J. Melatonin sensitizes human myometrial cells to oxytocin in a protein kinase C alpha/extracellular-signal regulated kinase-dependent manner. J Clin Endocrinol Metab. 2010 Jun;95(6):2902-8. doi: 10.1210/jc.2009-2137. Epub 2010 Apr 9. — View Citation

Sharkey JT, Puttaramu R, Word RA, Olcese J. Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells. J Clin Endocrinol Metab. 2009 Feb;94(2):421-7. doi: 10.1210/jc.2008-1723. Epub 2008 Nov 11. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of contractions per hour Number of contractions per hour Immediately upon completion of intervention
Secondary Binary proportion of 4 or less compared to 5+ contractions per hour Compare proportion proportions among each treatment group Immediately upon completion of intervention
See also
  Status Clinical Trial Phase
Completed NCT00163579 - The Impact of Bryophyllum on Preterm Delivery Phase 4
Completed NCT01868308 - Screening To Obviate Preterm Birth N/A